IL160109A0 - Topical pharmaceutical formulation - Google Patents

Topical pharmaceutical formulation

Info

Publication number: IL160109A0
Authority: IL; Israel
Prior art keywords: pharmaceutical formulation; topical pharmaceutical; admixture; composition; active agent
Prior art date: 2001-07-24

Application number

IL16010902A

Other languages

English (en)

Original Assignee

Advanced Biotechnologies

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-24

Filing date

2002-07-23

Publication date

2004-06-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23190223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL160109(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-07-23 Application filed by Advanced Biotechnologies filed Critical Advanced Biotechnologies

2004-06-20 Publication of IL160109A0 publication Critical patent/IL160109A0/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
230000000699 topical effect Effects 0.000 title 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
229910021485 fumed silica Inorganic materials 0.000 abstract 1
229920001296 polysiloxane Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Inorganic Chemistry (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL16010902A 2001-07-24 2002-07-23 Topical pharmaceutical formulation IL160109A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30754801P	2001-07-24	2001-07-24
PCT/GB2002/003387 WO2003009877A1 (en)	2001-07-24	2002-07-23	Topical pharmaceutical formulation

Publications (1)

Publication Number	Publication Date
IL160109A0 true IL160109A0 (en)	2004-06-20

Family

ID=23190223

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16010902A IL160109A0 (en)	2001-07-24	2002-07-23	Topical pharmaceutical formulation
IL160109A IL160109A (en)	2001-07-24	2004-01-28	Medication for topical treatment

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL160109A IL160109A (en)	2001-07-24	2004-01-28	Medication for topical treatment

Country Status (20)

Country	Link
US (1)	US8263114B2 (pt)
EP (1)	EP1409034B1 (pt)
JP (1)	JP3778559B2 (pt)
KR (1)	KR101009267B1 (pt)
CN (1)	CN1234426C (pt)
AT (1)	ATE331537T1 (pt)
AU (1)	AU2002317981B2 (pt)
BR (1)	BRPI0211282B8 (pt)
CA (1)	CA2454673C (pt)
DE (1)	DE60212847T2 (pt)
DK (1)	DK1409034T3 (pt)
ES (1)	ES2268061T3 (pt)
IL (2)	IL160109A0 (pt)
MX (1)	MXPA04000444A (pt)
NO (1)	NO334175B1 (pt)
NZ (1)	NZ529957A (pt)
PT (1)	PT1409034E (pt)
RU (1)	RU2306121C2 (pt)
WO (1)	WO2003009877A1 (pt)
ZA (1)	ZA200400488B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070237834A1 (en) *	2003-04-18	2007-10-11	Bioderm Research	Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
NZ545001A (en) *	2003-07-03	2009-09-25	Univ St Andrews	Zeolites for delivery of nitric oxide
CA2587029C (en) *	2004-11-07	2013-09-10	The Cupron Corporation	Methods and materials for treating wounds, burns, and skin conditions
US20110046532A1 (en) *	2006-01-30	2011-02-24	Sanjeev Kaila	composition including a silicone-based polymer and a method of treating skin disorders using the composition
CA2692187A1 (en) *	2007-06-29	2009-01-08	Carmanah Technologies Corp.	Intelligent area lighting system
UA28103U (uk)	2007-07-12	2007-11-26	Ольга Олександрівна Біляєва	Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
GB0821345D0 (en)	2008-11-21	2008-12-31	P Q Silicas Uk Ltd	Composition and dressing with nitric oxide
WO2010079209A2 (en) *	2009-01-08	2010-07-15	Golub Alexandr A	Compositions for treating wounds and skin conditions
US20100322875A1 (en) *	2009-06-18	2010-12-23	Advanced Bio-Technologies, Inc.	Silicone scar treatment preparation
MX2012000827A (es) *	2009-07-17	2012-03-26	Carefusion 2200 Inc	Particulas que incorporan agentes antimicrobianos.
RU2429820C2 (ru) *	2009-09-24	2011-09-27	Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН")	Антисептическая мазь наружного применения (2 варианта)
WO2011056116A1 (en) *	2009-11-03	2011-05-12	Lipidor Ab	Composition for promoting wound healing
NZ599933A (en)	2009-11-03	2014-08-29	Lipidor Ab	Lipid layer forming composition for administration onto a surface of a living organism
ES2831299T3 (es) *	2010-06-17	2021-06-08	Covalon Tech Inc	Apósito para heridas a base de silicona antimicrobiano
WO2012150890A1 (en) *	2011-05-02	2012-11-08	Lipidor Ab	Antibacterial composition
US20130144225A1 (en)	2011-12-06	2013-06-06	Jessica Rowen	Method And Device For Scar Management
TWI474823B (zh) *	2013-09-25	2015-03-01	Far Eastern New Century Corp	疤痕凝膠的組成物
US9226890B1 (en)	2013-12-10	2016-01-05	Englewood Lab, Llc	Polysilicone base for scar treatment
US9622483B2 (en)	2014-02-19	2017-04-18	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en)	2014-02-19	2021-06-22	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en)	2014-02-19	2021-06-22	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106729963A (zh) *	2016-12-22	2017-05-31	苏州迈达医疗器械有限公司	一种硅酮凝胶敷料及其生产工艺
US10496949B2 (en)	2017-01-04	2019-12-03	Christopher Zoumalan	Compositions and methods for treating cutaneous conditions
RU2674445C1 (ru) *	2017-12-11	2018-12-10	Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА)	Спрей для наружного применения спиртовой
CN108714141A (zh) *	2018-05-29	2018-10-30	南京华开生物科技有限公司	硅酮疤痕喷剂
EP3827051A4 (en) *	2018-07-26	2022-03-02	Exciton Pharma Corp.	OXIDANT VEHICLES AND DELIVERY SYSTEMS
WO2020061671A1 (en) *	2018-09-26	2020-04-02	Exaltexx Inc.	Winterized maturing agent, viscosity reducer and production enhancer
US11433016B2 (en)	2019-03-28	2022-09-06	L'oreal	Cosmetic compositions for skin
US11364190B2 (en)	2019-07-30	2022-06-21	L'oreal	Acid perfluoro-free self-foaming facial cleanser composition
US11207255B2 (en)	2019-07-30	2021-12-28	L'oreal	Perfluoro-free self-foaming facial cleanser composition
US12109279B2 (en)	2020-08-25	2024-10-08	L'oreal	Self-bubbling peel-away cleansing mask
US11213473B1 (en)	2020-09-18	2022-01-04	Christopher Zoumalan	Skin brightening composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0618899B2 (ja) *	1987-06-30	1994-03-16	品川燃料株式会社	抗菌性ゼオライト含有フィルム
US5292530A (en) *	1991-06-02	1994-03-08	Helene Curtis, Inc.	Stable anhydrous topically-active composition and suspending agent therefor
JPH049327A (ja)	1990-04-04	1992-01-14	Kootec Kk	創傷被覆材
DE4034705A1 (de) *	1990-10-31	1992-05-07	Martin Neumann	Wundverschluss
FR2678513B1 (fr) *	1991-07-03	1995-06-30	Laboratoires Hygiene Dietetique	Pansement cicatrisant.
JPH11509442A (ja)	1995-07-19	1999-08-24	イノベイティブ・テクノロジーズ・リミテッド	創傷処置組成物
US5833998A (en) *	1995-11-06	1998-11-10	The Procter & Gamble Company	Topical compositions for regulating the oily/shiny appearance of skin
JPH09194350A (ja)	1996-01-19	1997-07-29	Morishita Jintan Kk	創傷被覆材
US6231259B1 (en) *	1996-07-26	2001-05-15	The Gillette Company	Viscous product dispenser with porous dome
US5741509A (en) *	1996-08-26	1998-04-21	Alvin S. Berlat	Silicone wound dressing
AU1923199A (en) *	1997-12-17	1999-07-05	Hemodynamics, Inc.	Sealing media for surgery and wound closure
US6183766B1 (en) *	1999-02-12	2001-02-06	The Procter & Gamble Company	Skin sanitizing compositions
CN1343114A (zh)	1999-02-12	2002-04-03	宝洁公司	皮肤卫生处理组合物
GB0007140D0 (en) *	1999-09-27	2000-05-17	Dow Corning Sa	Scar treatment composition
AU2001256347A1 (en)	2000-05-23	2001-12-03	Unilever Plc	Deodorant and/or antiperspirant compositions
US8486374B2 (en) *	2003-08-04	2013-07-16	Foamix Ltd.	Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060110415A1 (en) *	2004-11-22	2006-05-25	Bioderm Research	Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080292560A1 (en) *	2007-01-12	2008-11-27	Dov Tamarkin	Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
TW200932292A (en) *	2007-09-30	2009-08-01	Valeant Pharmaceuticals Int	Silicone gel-based compositions for wound healing and scar reduction

2002
- 2002-07-23 DK DK02747591T patent/DK1409034T3/da active
- 2002-07-23 MX MXPA04000444A patent/MXPA04000444A/es active IP Right Grant
- 2002-07-23 ES ES02747591T patent/ES2268061T3/es not_active Expired - Lifetime
- 2002-07-23 CA CA2454673A patent/CA2454673C/en not_active Expired - Lifetime
- 2002-07-23 WO PCT/GB2002/003387 patent/WO2003009877A1/en not_active Ceased
- 2002-07-23 US US10/480,719 patent/US8263114B2/en active Active
- 2002-07-23 NZ NZ529957A patent/NZ529957A/en not_active IP Right Cessation
- 2002-07-23 KR KR1020047001045A patent/KR101009267B1/ko not_active Expired - Lifetime
- 2002-07-23 BR BRPI0211282A patent/BRPI0211282B8/pt not_active IP Right Cessation
- 2002-07-23 EP EP02747591A patent/EP1409034B1/en not_active Expired - Lifetime
- 2002-07-23 JP JP2003515269A patent/JP3778559B2/ja not_active Expired - Lifetime
- 2002-07-23 DE DE60212847T patent/DE60212847T2/de not_active Expired - Lifetime
- 2002-07-23 IL IL16010902A patent/IL160109A0/xx active IP Right Grant
- 2002-07-23 AU AU2002317981A patent/AU2002317981B2/en not_active Expired
- 2002-07-23 RU RU2004105164/15A patent/RU2306121C2/ru active
- 2002-07-23 AT AT02747591T patent/ATE331537T1/de active
- 2002-07-23 PT PT02747591T patent/PT1409034E/pt unknown
- 2002-07-23 CN CNB028140214A patent/CN1234426C/zh not_active Expired - Lifetime
2004
- 2004-01-22 ZA ZA2004/00488A patent/ZA200400488B/en unknown
- 2004-01-23 NO NO20040319A patent/NO334175B1/no not_active IP Right Cessation
- 2004-01-28 IL IL160109A patent/IL160109A/en unknown

Also Published As

Publication number	Publication date
ZA200400488B (en)	2005-06-29
MXPA04000444A (es)	2004-10-27
CA2454673A1 (en)	2003-02-06
HK1061362A1 (en)	2004-09-17
EP1409034B1 (en)	2006-06-28
PT1409034E (pt)	2006-11-30
BR0211282B1 (pt)	2018-01-09
BR0211282A (pt)	2004-08-03
CN1234426C (zh)	2006-01-04
KR20040032864A (ko)	2004-04-17
DE60212847D1 (de)	2006-08-10
DK1409034T3 (da)	2006-10-30
WO2003009877A1 (en)	2003-02-06
JP2005502639A (ja)	2005-01-27
NO20040319L (no)	2004-01-23
CN1527729A (zh)	2004-09-08
IL160109A (en)	2008-04-13
RU2306121C2 (ru)	2007-09-20
ATE331537T1 (de)	2006-07-15
AU2002317981B2 (en)	2006-12-07
NZ529957A (en)	2005-11-25
US20040234474A1 (en)	2004-11-25
BRPI0211282B8 (pt)	2021-05-25
CA2454673C (en)	2011-04-26
US8263114B2 (en)	2012-09-11
NO334175B1 (no)	2014-01-06
KR101009267B1 (ko)	2011-01-18
RU2004105164A (ru)	2005-06-27
JP3778559B2 (ja)	2006-05-24
ES2268061T3 (es)	2007-03-16
DE60212847T2 (de)	2007-06-14
EP1409034A1 (en)	2004-04-21

Legal Events

Date	Code	Title
2008-11-27	FF	Patent granted
2009-02-11	KB	Patent renewed
2010-04-14	KB	Patent renewed

Publication	Publication Date	Title
IL160109A0 (en)	2004-06-20	Topical pharmaceutical formulation
AU3539001A (en)	2001-07-24	Chip that comprises an active agent and an integrated heating element
AU2002343191A1 (en)	2003-05-06	Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
IL159584A0 (en)	2004-06-01	Pharmaceutical formulation comprising a proton pump inhibitor and antacids
HUP0300855A3 (en)	2012-01-30	Peptidmomimetic protease inhibitors, pharmaceutical compositions and their use
IL152339A0 (en)	2003-05-29	Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
BR0107869A (pt)	2002-11-05	Composições farmacêuticas eletrogiradas
HUP0301163A3 (en)	2008-08-28	7-substituted tetracycline dervatives, pharmaceutical compositions containing them and their use
IL158076A0 (en)	2004-03-28	Benzamidine derivatives and pharmaceutical compositions containing the same
HUP0300720A3 (en)	2009-04-28	Serine protease inhibitors, pharmaceutical compositions containing them and their use
AU2002335046A1 (en)	2003-05-06	The use of proton sequestering agents in drug formulations
IL157741A0 (en)	2004-03-28	Pharmaceutical compositions containing an antihyperplastic active agent
AU2001236457A1 (en)	2001-07-24	Compounds and compositions for delivering active agents
AU2002342907A1 (en)	2003-06-10	Gel capsules containing active ingredients and use thereof
GB0101035D0 (en)	2001-02-28	Formulation and use thereof
IL159591A0 (en)	2004-06-01	Pharmaceutical compositions containing terbinafin and use thereof
ZA200401591B (en)	2004-06-24	Wound dressing.
DE60112756D1 (de)	2005-09-22	Racecadotril enthaltende trockene pulverformulierung
IL155297A0 (en)	2003-11-23	Kahalalide f formulation
AU2002316200A1 (en)	2002-12-23	Compound and composition for delivering active agents
HUP0300128A3 (en)	2004-03-29	Male contraceptive composition comprising norethisterone and its use
AU2001272552A1 (en)	2002-02-13	Oxygen-enriched agent and the use thereof for therapeutic purposes
AU2001295301A1 (en)	2002-07-08	Medicinal composition and in particular its use in fluid therapy
AU2002302684A1 (en)	2002-10-21	Film-forming composition for topical use and use thereof for delivering active agents
PL360706A1 (en)	2004-09-20	Aqueous compositions comprising protease and/or amylase